276 related articles for article (PubMed ID: 24861491)
41. mTOR dysregulation and tuberous sclerosis-related epilepsy.
Curatolo P; Moavero R; van Scheppingen J; Aronica E
Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
[TBL] [Abstract][Full Text] [Related]
42. Epilepsy surgery of focal cortical dysplasia-associated tumors.
Cossu M; Fuschillo D; Bramerio M; Galli C; Gozzo F; Pelliccia V; Casaceli G; Tassi L; Lo Russo G
Epilepsia; 2013 Dec; 54 Suppl 9():115-22. PubMed ID: 24328884
[TBL] [Abstract][Full Text] [Related]
43. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
Gerasimenko A; Baldassari S; Baulac S
Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
[TBL] [Abstract][Full Text] [Related]
44. Focal cortical dysplasia: an update on diagnosis and treatment.
Guerrini R; Barba C
Expert Rev Neurother; 2021 Nov; 21(11):1213-1224. PubMed ID: 33834938
[TBL] [Abstract][Full Text] [Related]
45. Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year.
Serino D; Freri E; Ragona F; D'Incerti L; Bernardi B; Di Ciommo V; Granata T; Vigevano F; Fusco L
Epilepsy Res; 2015 Jan; 109():203-9. PubMed ID: 25524860
[TBL] [Abstract][Full Text] [Related]
46. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification.
Martinoni M; Marucci G; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Giulioni M
Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941
[TBL] [Abstract][Full Text] [Related]
47. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
[TBL] [Abstract][Full Text] [Related]
48. DEPDC5 as a potential therapeutic target for epilepsy.
Myers KA; Scheffer IE
Expert Opin Ther Targets; 2017 Jun; 21(6):591-600. PubMed ID: 28406046
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic methods and treatment options for focal cortical dysplasia.
Guerrini R; Duchowny M; Jayakar P; Krsek P; Kahane P; Tassi L; Melani F; Polster T; Andre VM; Cepeda C; Krueger DA; Cross JH; Spreafico R; Cosottini M; Gotman J; Chassoux F; Ryvlin P; Bartolomei F; Bernasconi A; Stefan H; Miller I; Devaux B; Najm I; Giordano F; Vonck K; Barba C; Blumcke I
Epilepsia; 2015 Nov; 56(11):1669-86. PubMed ID: 26434565
[TBL] [Abstract][Full Text] [Related]
50. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
51. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
52. Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation.
Hadouiri N; Darmency V; Guibaud L; Arzimanoglou A; Sorlin A; Carmignac V; Rivière JB; Huet F; Luu M; Bardou M; Thauvin-Robinet C; Vabres P; Faivre L
Eur J Med Genet; 2020 Nov; 63(11):104036. PubMed ID: 32805448
[TBL] [Abstract][Full Text] [Related]
53. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.
Ljungberg MC; Sunnen CN; Lugo JN; Anderson AE; D'Arcangelo G
Dis Model Mech; 2009; 2(7-8):389-98. PubMed ID: 19470613
[TBL] [Abstract][Full Text] [Related]
54. Epilepsies associated with focal cortical dysplasias (FCDs).
Najm IM; Tassi L; Sarnat HB; Holthausen H; Russo GL
Acta Neuropathol; 2014 Jul; 128(1):5-19. PubMed ID: 24916270
[TBL] [Abstract][Full Text] [Related]
55. Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.
Avansini SH; Torres FR; Vieira AS; Dogini DB; Rogerio F; Coan AC; Morita ME; Guerreiro MM; Yasuda CL; Secolin R; Carvalho BS; Borges MG; Almeida VS; Araújo PAOR; Queiroz L; Cendes F; Lopes-Cendes I
Ann Neurol; 2018 Mar; 83(3):623-635. PubMed ID: 29461643
[TBL] [Abstract][Full Text] [Related]
56. [Advances of pathological research and classification in malformations of cortical development associated with refractory epilepsy].
Fu YJ; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):419-424. PubMed ID: 38678320
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.
McDaniel SS; Wong M
Neurosci Lett; 2011 Jun; 497(3):231-9. PubMed ID: 21354266
[TBL] [Abstract][Full Text] [Related]
58. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
59. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
[TBL] [Abstract][Full Text] [Related]
60. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
Zhang L; Huang T; Teaw S; Bordey A
Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
